机器人辅助肾部分切除术与经皮冷冻消融治疗肾肿瘤的围手术期及局部控制结局:基于影像分期与RENAL评分匹配的比较
本研究回顾性比较2009-2016年间四中心647例T1肾肿瘤患者,按影像分期和RENAL评分1:1匹配后RAPN与PCA各177例。PCA组绝对复发率8.4%显著高于RAPN组2.8%(P=0.03),5年无复发生存率PCA组85%低于RAPN组95%(log-rank P=0.02)。多因素分析显示切缘阳性与治疗方式是局部复发的独立相关因素。
要点
- 匹配后PCA组绝对复发率8.4%高于RAPN组2.8%,5年无复发生存率85% vs 95%。
- 切缘阳性与治疗方式是与局部复发显著相关的两个因素。
- PCA组复发率可能因影像随访更密切而被高估。
核心结论
- 对于T1肾肿瘤,经皮冷冻消融后的局部复发率显著高于机器人辅助肾部分切除术。
- 治疗不完全是复发的主要相关标准。
- PCA组复发率可能因该组患者影像随访更密切而被高估。
研究设计与样本
- 回顾性研究,纳入2009至2016年间四中心接受RAPN或PCA治疗恶性肾肿瘤的全部患者。
- 共647例患者,其中470例行RAPN,177例行PCA。
- 采用影像肿瘤分期和RENAL肾测量评分进行1:1配对(matchit包,R软件3.2.2版)。
- PCA组所有患者均经活检证实恶性。
- 采用Cox回归(校正年龄、治疗类型、组织学类型和切缘)识别与局部复发时间相关的因素。
主要发现
- 匹配后RAPN组177例、PCA组177例,两组在肿瘤分期、RENAL评分、肿瘤大小(27.6 vs 25.9 mm;P=0.07)和性别比例上无显著差异。
- PCA组患者年龄仍显著更大(69.9 vs 59.8岁;P<0.001)。
- RAPN组绝对复发率为2.8%,PCA组为8.4%(P=0.03)。
- PCA组5年无复发生存率为85%,RAPN组为95%(log-rank P=0.02)。
- 多因素分析中,切缘阳性和治疗类型是与局部复发显著相关的两个因素(P<0.001和P=0.046)。
关键数值与推荐
- RAPN组切缘阳性经组织学定义,PCA组经影像学定义。
- 匹配后肿瘤大小RAPN组27.6 mm vs PCA组25.9 mm(P=0.07)。
- 匹配后年龄RAPN组59.8岁 vs PCA组69.9岁(P<0.001)。
- 绝对复发率RAPN组2.8% vs PCA组8.4%(P=0.03)。
- 5年无复发生存率PCA组85% vs RAPN组95%(log-rank P=0.02)。
临床怎么用
- 对于T1肾肿瘤,选择PCA需权衡其较RAPN更高的局部复发风险。
- 治疗后应关注切缘状态,切缘阳性与局部复发显著相关。
- PCA术后影像随访强度可能影响复发检出率,解读复发率比较时需考虑随访差异。
局限性
- 回顾性研究设计。
- 匹配后PCA组患者年龄仍显著大于RAPN组。
- PCA组复发率可能因影像随访更密切而被高估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the oncological outcomes of percutaneous cryoablation (PCA) vs robot-assisted partial nephrectomy (RAPN) for the treatment of T1 renal tumours. PATIENTS AND METHODS: We conducted a retrospective study in all patients treated by RAPN or PCA for malignant renal tumours in one of four centres between 2009 and 2016. Tumours were paired one by one using radiological tumour stage and RENAL nephrometry score (package matchit, R software version 3.2.2). Malignancy was confirmed by biopsy for all patients in the PCA group. Patient characteristics before and after matching and oncological results were compared between the two groups. Cox regression, adjusted for age, treatment type, histological type and margins, was used to identify factors associated with time to local recurrence. Positive margins were defined histologically in the RAPN group and radiologically in the PCA group. RESULTS: A total of 647 patients were identified; 470 underwent RAPN and 177 underwent PCA. After matching, there was no significant difference between the two groups (RAPN, n = 177; PCA, n = 177) with regard to tumour stage, RENAL nephrometry score, tumour size (27.6 vs 25.9 mm; P = 0.07) and gender ratio. Patients in the PCA group remained significantly older (69.9 vs 59.8 years; P < 0.001). The absolute recurrence rate was 2.8% in the RAPN group vs 8.4% in the PCA group (P = 0.03). The 5-year recurrence-free survival rate was 85% in the PCA group vs 95% in the RAPN group (log-rank P = 0.02). In multivariate analysis, the presence of positive margins and the type of treatment were the two factors significantly associated with local recurrence (P < 0.001 and P = 0.046, respectively). CONCLUSION: The local recurrence rate after PCA was significantly higher than after RAPN for T1 renal tumours. Incomplete treatment was the main criterion associated with recurrence. The recurrence rate may have been overestimated in the PCA group because of closer radiological follow-up in these patients.
引用
- Fraisse G, Colleter L, Peyronnet B, et al. Peri-operative and local control outcomes of robot-assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal score. BJU Int. 2018. PMID: 30153399. doi:10.1111/bju.14530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。